As shown in Figure 1C, METH treatment under the NAT did not induce any depression-like behaviors in TST (T1: P = 0.782; T2: P = 0.390) and FST (T1: P = 0.442; T2: P = 0.365). This evidence concerns the gene BRD2 and depressive disorder.